# Selexagen Therapeutics, Inc. — Form D/A

Selexagen Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2011-07-25. The offering totals $597K, of which $597K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2011-07-25
- Form: D/A
- Accession: 0001507335-11-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $597K
- Amount sold: $597K
- Minimum investment: $1
- Investors: 4
- Date of first sale: 2010-11-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-151616

## Issuer

- Name: Selexagen Therapeutics, Inc.
- CIK: 0001507335
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 4653 CARMEL MOUNTAIN ROAD, SAN DIEGO, CA, 92130
- Phone: (619) 252-4024

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Scott L Glenn | Director | Boulder, CO |
| Patrick G O'Connor | Director | San Diego, CA |
| Lauren G Otsuki | Director | San Diego, CA |
| Randall G Woods | Director | San Diego, CA |
| Patrick G O'Connor | Executive Officer | San Diego, CA |
| Lauren G Otsuki | Executive Officer | San Diego, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2010-12-09](https://search.stillhousedata.com/formd/0001507335-10-000001) | D | $497K | $497K |

## More

- [CIK 1507335 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1507335&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001507335-11-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.